N-Acetylcysteine Market is Anticipated to Reach Around USD 2.2 BN in 2027 | Credence Research

The global N-Acetylcysteine market generated revenue of around USD 1032.6 million in 2020 and is anticipated to grow at a CAGR of over 21.3% during the forecast period from 2021 to 2027 to reach around USD 2200 million in 2027.

N-Acetylcysteine is a byproduct obtained during the production of glutathione. N-acetylcysteine is the medication used for treating medical conditions like cystic fibrosis and asthma. After inhalation, it helps in thinning of mucus. It also helps in the reduction of inflammation. It is also useful for treating dry eye, acetaminophen poisoning, and flu among others.

Key Trends in Global N-Acetylcysteine Market

Increasing demand for N-Acetylcysteine from healthcare

When there is excess acetaminophen in the body, there is chance of accumulation of toxic NAPQI and it leads to reaction with hepatic enzymes. It can lead to damage of liver cells and eventually liver failure. N-acetylcysteine is very effective for the treatment of acetaminophen poisoning.  N-acetylcysteine is very effective in controlling the inflammations. N-acetylcysteine has shown its efficacy in the treatment of respiratory diseases such as idiopathic pulmonary fibrosis and obstructive pulmonary disease among others. N-acetylcysteine inhibits HIV expression in both acute and chronic infection models. Furthermore, it prevents HIV replication in peripheral blood mononuclear cells. When oxidative stress occurs, it aids in the maintenance of thiol levels within cells. It also replenishes GSH levels. N-acetylcysteine is used to treat millions of HIV patients around the world. Many clinical studies have shown that N-acetylcysteine has a positive impact on psychological disorders such as substance addiction, anxiety, attention deficit hyperactivity disorder, bipolar disorder, depression, obsessive compulsive disorder, schizophrenia, and impulse control disorders, among others.

Download Free Sample PDF including full TOC, Tables and [email protected] https://www.credenceresearch.com/sample-request/60311

Impact of COVID 19 on Global N-Acetylcysteine Market

COVID 19 has had a significant impact on the N-Acetylcysteine market’s revenue generation. Citing the COVID-19 pandemic, governments all over the world imposed strict regulations on the movement of people and goods, as well as the operation of industrial units and other workplaces. Treatment for many other medical conditions was delayed as healthcare institutions focused on COVID-19 patients. Furthermore, due to lockdown restrictions, there was a decrease in N-acetylcysteine production. It resulted in a decrease in demand for N-acetylcysteine and a 20.2 percent decrease in global N-acetyl revenue in 2020 when compared to 2019. However, the use of N-Acetylcysteine for treating COVID-19 patients with severe pulmonary ailments aided in the market’s slight recovery.

Global N-Acetylcysteine Market by Product Type Insights

Spray, tablet and tracheal drip are the major product types of N-Acetylcysteine. Spray is ideal for lung related ailments. Tracheal drip is ideal for N-acetylcysteine Tracheal drips find more demand for the treatment of acetaminophen overdose, kidney and bladder ailments, and HIV ailments. Tablets are ideal for psychiatric ailments, inflammation, and flu among others.

Global N-Acetylcysteine Market by Application Insights

Medicine and nutritional supplements are the major application areas for N-acetylcysteine market. Medicine application accounted for the vast part of revenue generated in the global N-acetylcysteine market in 2020, with a share of 42.3%.

Global N-Acetylcysteine Market by Regional Insights

North America was the largest market for N-Acetylcysteine in 2020 and accounted for over 39.1% share in total revenue generation. Presence of major pharmaceutical research and development centers in the region allow early availability of the product variants. N-acetylcysteine is widely used for treating ailments related to lungs and HIV in the region. Given the severe pollution in major cities in Asia-Pacific, there is demand for N-acetylcysteine for the treatment of lung ailments. There are nearly 23.8 million HIV infected individuals in Africa. N-acetylcysteine is finding more demand in Africa for the treatment of HIV patients. In Europe, it is used for the treatment of inflammations and acetaminophen poisoning.

To Understand How Covid-19 Impact Is Covered in This Report – https://www.credenceresearch.com/report/n-acetylcysteine-market

Global N-Acetylcysteine Market Competitive Landscape

Most prominent players in the global Horizontal Directional Drilling market include Cheng Yi Pharmaceutical Co Ltd, Donboo Amino Acid Co Ltd, Manus Aktteva Biopharma LLP, Moehs Group, Ningbo Zhenhai Haide Amino Acid, Nippon Rika Co Ltd, PharmaZell, Xinyi Hanling Biological Engineering Co Ltd, Wuxi Enovo Chemical Co Ltd, and Zambon Pharma among others. The report covers very detailed profiles of these key players.

Market Segmentation

Global N-Acetylcysteine Market by Product Type, 2015 – 2027

· Spray

· Tablet

· Tracheal Drip

Global N-Acetylcysteine Market by Application, 2015 – 2027

· Medicine

· Nutritional Supplements

· Others

Global N-Acetylcysteine Market by Region, 2015 – 2027

· North America

· Europe

· Asia Pacific

· Latin America

· Middle East and Africa

Global N-Acetylcysteine Market: Key Players

· Cheng Yi Pharmaceutical Co Ltd

· Donboo Amino Acid Co Ltd

· Manus Aktteva Biopharma LLP

· Moehs Group

· Ningbo Zhenhai Haide Amino Acid

· Nippon Rika Co Ltd

· PharmaZell

· Xinyi Hanling Biological Engineering Co Ltd

· Wuxi Enovo Chemical Co Ltd

. Zambon Pharma

Download Free Sample PDF including full TOC, Tables and [email protected] https://www.credenceresearch.com/sample-request/60311

About Us
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives.

Contact Information:

Name: Chris Smith
Address: 105 N 1st ST #429,
(US/CANADA) Ph.: +1-800-361-8290
E-mail: [email protected]